ShadowBuys

Rep. Daniel S. Goldman sold Madrigal Pharmaceuticals (MDGL)

Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Apr 10, 2023

Transaction
Sold
Amount
$1K–$15K
Owner
Not stated
Traded
Apr 10, 2023
Disclosed
May 19, 2023
Days to disclose
39
Asset type
Stock
As filed
Madrigal Pharmaceuticals, Inc.
Industry
Biotechnology · Healthcare

Other trades in this filing

All of Goldman's trades →

Company context for MDGL

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. MDGLInsider purchase·SEC EDGAR

    MDGL: BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP reported buying shares

    5 reported purchases of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.

    Public: Nov 6, 2026Event / period: Nov 4, 2026Original source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.